The NAC for thrombolysis in acute stroke (NAC-S) trial (ClinicalTrials.gov: NCT04920448) is an ongoing phase 2 randomized study assessing the safety of NAC combined with IV tPA in AIS setting. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.